Literature DB >> 26887679

First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.

Lucas Engelhardt1, Martina Röhm2,3, Chrystelle Mavoungou4, Katharina Schindowski4, Annette Schafmeister4, Ulrich Simon1.   

Abstract

PURPOSE: Aerosol particle deposition in the human nasal cavity is of high interest in particular for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The objective of this study was the development and comparison of a numerical and experimental model to investigate various parameters for olfactory particle deposition within the complex anatomical nasal geometry.
METHODS: Based on a standardized nasal cavity, a computational fluid and particle dynamics (CFPD) model was developed that enables the variation and optimization of different parameters, which were validated by in vitro experiments using a constructed rapid-prototyped human nose model.
RESULTS: For various flow rates (5 to 40 l/min) and particle sizes (1 to 10 μm), the airflow velocities, the calculated particle airflow patterns and the particle deposition correlated very well with the experiment. Particle deposition was investigated numerically by varying particle sizes at constant flow rate and vice versa assuming the particle size distribution of the used nebulizer.
CONCLUSIONS: The developed CFPD model could be directly translated to the in vitro results. Hence, it can be applied for parameter screening and will contribute to the improvement of aerosol particle deposition at the olfactory cleft for CNS drug delivery in particular for biopharmaceuticals.

Entities:  

Keywords:  CFPD; nasal airflow; nose-to-brain drug delivery; olfactory cleft; standardized human nasal cavity

Mesh:

Substances:

Year:  2016        PMID: 26887679     DOI: 10.1007/s11095-016-1875-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  46 in total

Review 1.  Intranasal drug delivery for brain targeting.

Authors:  Tushar K Vyas; Aliasgar Shahiwala; Sudhanva Marathe; Ambikanandan Misra
Journal:  Curr Drug Deliv       Date:  2005-04       Impact factor: 2.565

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  Optimising nasal spray parameters for efficient drug delivery using computational fluid dynamics.

Authors:  K Inthavong; Z F Tian; J Y Tu; W Yang; C Xue
Journal:  Comput Biol Med       Date:  2008-05-12       Impact factor: 4.589

4.  Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method.

Authors:  Vipra Kundoor; Richard N Dalby
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

5.  Numerical simulation of normal nasal cavity airflow in Chinese adult: a computational flow dynamics model.

Authors:  Jie Tan; Demin Han; Jie Wang; Ting Liu; Tong Wang; Hongrui Zang; Yunchuan Li; Xiangdong Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-22       Impact factor: 2.503

Review 6.  Protein stability in pulmonary drug delivery via nebulization.

Authors:  Sebastian P Hertel; Gerhard Winter; Wolfgang Friess
Journal:  Adv Drug Deliv Rev       Date:  2014-10-12       Impact factor: 15.470

7.  Prediction of protein degradation during vibrating mesh nebulization via a high throughput screening method.

Authors:  Sebastian Hertel; Thomas Pohl; Wolfgang Friess; Gerhard Winter
Journal:  Eur J Pharm Biopharm       Date:  2014-04-04       Impact factor: 5.571

8.  Controlling the droplet size of formulations nebulized by vibrating-membrane technology.

Authors:  Moritz Beck-Broichsitter; Marie-Christine Knuedeler; Werner Seeger; Thomas Schmehl
Journal:  Eur J Pharm Biopharm       Date:  2014-03-20       Impact factor: 5.571

9.  Contribution of the maxillary sinus to the modularity and variability of nasal cavity shape in Japanese macaques.

Authors:  Tsuyoshi Ito; Takeshi D Nishimura; Yuzuru Hamada; Masanaru Takai
Journal:  Primates       Date:  2014-08-07       Impact factor: 2.163

10.  Impacts of fluid dynamics simulation in study of nasal airflow physiology and pathophysiology in realistic human three-dimensional nose models.

Authors:  De Yun Wang; Heow Peuh Lee; Bruce R Gordon
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-11-13       Impact factor: 3.372

View more
  4 in total

Review 1.  Imaging of intranasal drug delivery to the brain.

Authors:  Michael C Veronesi; Mosa Alhamami; Shelby B Miedema; Yeonhee Yun; Miguel Ruiz-Cardozo; Michael W Vannier
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

Review 2.  A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.

Authors:  Nishat Fatima; Vichitra Kaushik; Amjad Ayoub
Journal:  Iran J Med Sci       Date:  2021-05

3.  Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System.

Authors:  Johannes Flamm; Sunniva Hartung; Stella Gänger; Frank Maigler; Claudia Pitzer; Katharina Schindowski
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 4.  Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa.

Authors:  Stella Gänger; Katharina Schindowski
Journal:  Pharmaceutics       Date:  2018-08-03       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.